Home › Studies › PRJNA728908
PRJNA728908 SRP319464

Baseline gut microbiota in NAFLD prospective cohort

Gut microbiota of baseline individuals in a 4.6-year non-alcoholic fatty liver disease prospective study

176 baseline faecal samples from a Shanghai, China cohort followed 4.6 years, comparing individuals who progressed to NAFLD versus matched controls who remained NAFLD-free, in a case-control design. machine-written summary

176 samples · 176 runs · CN · Age unknown · 2022 · 7.36 Gbp / sample · cohort Risk assessment with gut microbiome and metabolite

Sources
✓Sequence archive 1,142✓Abstract / description 176✓Full text 176○Supplementary tables✓External resources 176–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,142 sample values (collection date, country, health condition, health condition detail, latitude, location locality, longitude)
✓ Abstract / description176 sample values (subject id)
✓ Full text176 sample values (location region) · PMC12763994, PMC9746350
○ Supplementary tablesfiles read; no table could be matched to the samples
✓ External resources176 sample values (antibiotic exposure) · from BugSigDB
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

design observational_with_procedure

Samples at a glance
1 sampling locations · 1 country
Age
adult176
Condition
cardiometabolic_other86
Country
CN176
Body site
primary176
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 170 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 6 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 7.36 Gbp per sample0130Gbp
Community composition
Prevotella 14.1%Phocaeicola 14.0%Bacteroides 11.7%Faecalibacterium 6.4%Roseburia 4.5%Alistipes 3.7%Lachnospira 3.0%Acetatifactor 1.7%Blautia_A 1.6%Parabacteroides 1.4%Mediterraneibacter 1.3%Ruminococcoides 1.3%not assigned to a genus 3.8%other genera 31.6%

Genera, mean relative abundance over 155 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category176 100%
country176 100%176
health_condition86 49%86
subject_id176 100%176
antibiotic_exposure176 100%176
collection_date176 100%176
detailed_location176 100%
health_condition_detail176 100%176
latitude176 100%176
location_locality176 100%176
location_region176 100%176
longitude176 100%176
Papers (4)
  • Risk assessment with gut microbiome and metabolite markers in NAFLD development. 2022 PMID 35675435 PMC9746350 own_data
  • Discovery of robust and highly specific microbiome signatures of non-alcoholic fatty liver disease. 2025 PMID 39810263 PMC11730835 unsure
  • Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome. 2025 PMID 41087898 PMC12522779 unsure
  • Characterization of the gut virome in patients with nonalcoholic fatty liver disease. 2025 PMID 41316248 PMC12763994 unsure
Details
Archive description

A 4.6-year non-alcoholic fatty liver disease prospective (NAFLD) study. Faecal samples of individuals were collected at baseline where no one was diagnosed with NAFLD.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by opus_adjudicated with confidence 0.85. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site study.description · “Faecal samples of individuals were collected”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN19107326antibiotic_exposurenoR20.60external.bugsigdb sourceAntibiotics exclusion: 2 weeks
SAMN19107326collection_date2014-05R10.90biosample.attribute:collection_date2014-05
SAMN19107326countryCNR10.90sample.attr.geo_loc_nameChina: Shanghai
SAMN19107326health_conditioncardiometabolic_otherR10.90biosample_attrNAFLD
SAMN19107326health_condition_detailNAFLDR10.90sample.attr.group_by_nafld_status_in_2018NAFLD
SAMN19107326latitude30.5300R10.90biosample.attribute:lat_lon30.53 N 121.48 E
SAMN19107326location_localityShanghaiR10.85biosample.attribute:geo_loc_nameChina: Shanghai
SAMN19107326location_regionShanghaiR30.70paper.fulltext.methodsa suburb of Shanghai, China
SAMN19107326longitude121.4800R10.90biosample.attribute:lat_lon30.53 N 121.48 E
SAMN19107326subject_idSAMN19107326R40.65design.one_sample_per_subject:descriptionFaecal samples of individuals were collected at baseline where no one was diagnosed with NAFLD.
Sequencing

176 runs over 176 samples · mean 7.46 Gbp per run (median 7.36 Gbp, total 1,312.93 Gbp; 176 runs with a base count) · layout PAIRED 176 · platform ILLUMINA 176 · models Illumina NovaSeq 6000 (176) · 88% of runs with a Sandpiper profile · first public 2022-07-12 – 2022-09-30

Authors (39)

Leung H first · Long X · Ni Y · Qian L · Nychas E · Siliceo SL · Pohl D · Hanhineva K · Liu Y · Xu A · Nielsen HB · Belda E · Clément K · Loomba R · Li H · Jia W · Panagiotou G last · Marfil-Sánchez A · Chen X · Mirhakkak M · Nieuwdorp M · Zheng N first · Wang D · Xing G · Gao Y · Li S · Liu J · Kang J · Sha S · Cheng L · Fan S · Yu J · Yan Q · Jiang C last · Wang L first · Liu M · Yuan Q · Chen H · Mao S

Downloads

PRJNA728908.csv.gz (5.5 KB) · parquet (78.2 KB) — all 176 samples, every field with route and confidence · PRJNA728908_determinations.csv.gz (10.4 KB) — 1,670 evidence rows

Samples (176 · every field this project has values for · hover a cell for its source)
Loading the sample table…